ORNATINS - POTENT GLYCOPROTEIN-IIB-IIIA ANTAGONISTS AND PLATELET-AGGREGATION INHIBITORS FROM THE LEECH PLACOBDELLA-ORNATA

被引:78
|
作者
MAZUR, P
HENZEL, WJ
SEYMOUR, JL
LAZARUS, RA
机构
[1] GENENTECH INC, DEPT PROT ENGN, San Francisco, CA 94080 USA
[2] COLUMBIA UNIV, DEPT CHEM, NEW YORK, NY 10027 USA
[3] GENENTECH INC, DEPT PROT CHEM, San Francisco, CA USA
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1991年 / 202卷 / 03期
关键词
D O I
10.1111/j.1432-1033.1991.tb16472.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purification and characterization of six isoforms of ornatin, potent glycoprotein IIb-IIIa (GP IIb-IIIa) antagonists and platelet aggregation inhibitors are described. These isoforms were purified from whole leech homogenates of the leech Placobdella ornata, a North American leech commonly known as the turtle leech, by trichloroacetic acid precipitation, Sephadex G-50 size exclusion chromatography, GP IIb-IIIa affinity chromatography, and C18 reverse-phase HPLC. Each of the five completely sequenced isoforms, which range from 41 to 52 residues in length, contains the Arg-Gly-Asp (RGD) sequence, a common recognition sequence in adhesion proteins, as well as 6 cysteine residues; the positions of both of these features are conserved in the primary sequences. The amino acid sequences of ornatin isoforms B, C, D, and E are highly conserved, whereas ornatin A2 and A3 are less similar and lack 9 residues at the N-terminus. The ornatins are approximately 40% identical with decorsin, a GP IIb-IIIa antagonist isolated from the leech Macrobdella decora [Seymour, J. L., Henzel, W. J., Nevins, B., Stults, J. T. & Lazarus, R. A. (1990) J. Biol. Chem. 265, 10143-10147]; furthermore, the RGD sequence and 5 out of 6 cysteine residues are maintained in the same relative positions in both decorsin and ornatin. The ornatin isoforms do not exhibit significant similarity to any members of the snake-venom-derived family of GP IIb-IIIa antagonists [Dennis, M. S., Henzel, W. J., Pitti, R. M., Lipari, M. T., Napier, M. A., Deisher, T. A., Bunting, S. & Lazarus, R. A. (1990) Proc. Natl Acad. Sci. USA 87, 2471-2475] except in the RGD region of these proteins. The ornatin isoforms inhibit the binding of GP IIb-IIIa to immobilized fibrinogen with IC50 values ranging over 2.9-5.3 nM; ornatin isoforms A2, C, and E inhibit ADP-induced human platelet aggregation with IC50 values of about 130, 280, and 440 nM, respectively.
引用
收藏
页码:1073 / 1082
页数:10
相关论文
共 50 条
  • [31] SOLUTION STRUCTURE OF KISTRIN, A POTENT PLATELET-AGGREGATION INHIBITOR AND GP-IIB-IIIA ANTAGONIST
    ADLER, M
    LAZARUS, RA
    DENNIS, MS
    WAGNER, G
    SCIENCE, 1991, 253 (5018) : 445 - 448
  • [32] Differential inhibitory effects of platelet glycoprotein IIb/IIIa antagonists on aggregation induced by procoagulant agonists
    Ilveskero, S
    Lassila, R
    THROMBOSIS RESEARCH, 2006, 117 (03) : 291 - 297
  • [33] GLYCOPROTEIN-IIB/IIIA INHIBITOR ON PLATELET-AGGREGATION AND ACTIVATION AS DETERMINED BY PLATELET AGGREGOMETRY AND FLOW CYTOMETRIC ANALYSIS
    KOZA, MJ
    HOLNESS, S
    WALENGA, JM
    SHANKEY, TV
    REILLY, T
    BERMES, EW
    PIFARRE, R
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 996 - 996
  • [34] L-367,073 IS A SELECTIVE INHIBITOR OF PLATELET-AGGREGATION, ACTING AT PLATELET INTEGRIN GLYCOPROTEIN IIB IIIA
    GOULD, RJ
    ZHANG, GX
    MANNO, PD
    NUTT, RF
    LYNCH, RJ
    FRIEDMAN, PA
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 842 - 842
  • [35] THE EVALUATION OF A GLYCOPROTEIN IIB/IIIA INHIBITOR ON PLATELET-AGGREGATION AND ACTIVATION AS DETERMINED BY PLATELET AGGREGOMETRY AND FLOW CYTOMETRIC ANALYSIS
    HOLNESS, S
    KOZA, MJ
    WALENGA, JM
    SHANKEY, TV
    FAREED, J
    BERMES, EW
    BLOOD, 1994, 84 (10) : A687 - A687
  • [36] THE SECRETORY RELEASE REACTION INITIATED BY COMPLEMENT PROTEINS-C5B-9 OCCURS WITHOUT PLATELET-AGGREGATION THROUGH GLYCOPROTEIN-IIB-IIIA
    ANDO, B
    WIEDMER, T
    SIMS, PJ
    BLOOD, 1989, 73 (02) : 462 - 467
  • [37] Nonpeptide glycoprotein IIb/IIIa inhibitors: Substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists
    Liverton, NJ
    Armstrong, DJ
    Claremon, DA
    Remy, DC
    Baldwin, JJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (05) : 483 - 486
  • [38] A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: Comparison with other aggregation methodologies
    Storey, RF
    May, JA
    Wilcox, RG
    Heptinstall, S
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (04) : 1307 - 1311
  • [39] Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation
    Frelinger, AL
    Furman, MI
    Barnard, MR
    Krueger, LA
    Dae, MW
    Michelson, AD
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (09): : 1099 - 1101
  • [40] Monitoring of the glycoprotein IIb/IIIa inhibitors using the PFA-100 analyzer and platelet aggregation
    Hoppensteadt, DA
    Fu, K
    Lietz, H
    Fareed, J
    THROMBOSIS AND HAEMOSTASIS, 1999, : 262 - 262